1028 related articles for article (PubMed ID: 14564330)
1. Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure.
Isnard R; Pousset F; Chafirovskaïa O; Carayon A; Hulot JS; Thomas D; Komajda M
Am Heart J; 2003 Oct; 146(4):729-35. PubMed ID: 14564330
[TBL] [Abstract][Full Text] [Related]
2. Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure.
Selvais PL; Robert A; Ahn S; van Linden F; Ketelslegers JM; Pouleur H; Rousseau MF
J Card Fail; 2000 Sep; 6(3):201-7. PubMed ID: 10997745
[TBL] [Abstract][Full Text] [Related]
3. Plasma endothelin-1 levels and clinical correlates in patients with chronic heart failure.
Kinugawa T; Kato M; Ogino K; Osaki S; Igawa O; Hisatome I; Shigemasa C
J Card Fail; 2003 Aug; 9(4):318-24. PubMed ID: 13680553
[TBL] [Abstract][Full Text] [Related]
4. Clinical correlates of elevated plasma natriuretic peptides and Big endothelin-1 in a population of ambulatory patients with heart failure. A substudy of the Italian Network on Congestive Heart Failure (IN-CHF) registry. IN-CHF Investigators.
Masson S; Gorini M; Salio M; Lucci D; Latini R; Maggioni AP
Ital Heart J; 2000 Apr; 1(4):282-8. PubMed ID: 10824729
[TBL] [Abstract][Full Text] [Related]
5. B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure.
de Groote P; Dagorn J; Soudan B; Lamblin N; McFadden E; Bauters C
J Am Coll Cardiol; 2004 May; 43(9):1584-9. PubMed ID: 15120815
[TBL] [Abstract][Full Text] [Related]
6. Neurohormonal risk stratification for sudden death and death owing to progressive heart failure in chronic heart failure.
Berger R; Huelsmann M; Strecker K; Moertl D; Moser P; Bojic A; Pacher R
Eur J Clin Invest; 2005 Jan; 35(1):24-31. PubMed ID: 15638816
[TBL] [Abstract][Full Text] [Related]
7. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure.
Passino C; Maria Sironi A; Favilli B; Poletti R; Prontera C; Ripoli A; Lombardi M; Emdin M
Int J Cardiol; 2005 Sep; 104(1):39-45. PubMed ID: 16137508
[TBL] [Abstract][Full Text] [Related]
8. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
[TBL] [Abstract][Full Text] [Related]
9. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction.
Squire IB; O'Brien RJ; Demme B; Davies JE; Ng LL
Clin Sci (Lond); 2004 Sep; 107(3):309-16. PubMed ID: 15182235
[TBL] [Abstract][Full Text] [Related]
10. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction.
Richards AM; Nicholls MG; Espiner EA; Lainchbury JG; Troughton RW; Elliott J; Frampton C; Turner J; Crozier IG; Yandle TG
Circulation; 2003 Jun; 107(22):2786-92. PubMed ID: 12771003
[TBL] [Abstract][Full Text] [Related]
11. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.
Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV
J Heart Lung Transplant; 2007 May; 26(5):516-21. PubMed ID: 17449423
[TBL] [Abstract][Full Text] [Related]
12. Baseline and serial neurohormones in patients with congestive heart failure treated with and without bucindolol: results of the neurohumoral substudy of the Beta-Blocker Evaluation of Survival Study (BEST).
Frantz RP; Lowes BD; Grayburn PA; White M; Krause-Steinrauf H; Krishnan V; Uyeda L; Burnett JC;
J Card Fail; 2007 Aug; 13(6):437-44. PubMed ID: 17675057
[TBL] [Abstract][Full Text] [Related]
13. Multiparametric risk stratification in patients with mild to moderate chronic heart failure.
Scardovi AB; De Maria R; Coletta C; Aspromonte N; Perna S; Cacciatore G; Parolini M; Ricci R; Ceci V
J Card Fail; 2007 Aug; 13(6):445-51. PubMed ID: 17675058
[TBL] [Abstract][Full Text] [Related]
14. Is hormonal activation during exercise useful for risk stratification in patients with moderate congestive heart failure?
de Groote P; Soudan B; Lamblin N; Rouaix-Emery N; Mc Fadden E; Meurice T; Mouquet F; Bauters C
Am Heart J; 2004 Aug; 148(2):349-55. PubMed ID: 15309008
[TBL] [Abstract][Full Text] [Related]
15. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
[TBL] [Abstract][Full Text] [Related]
16. Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1.
Tsutamoto T; Wada A; Maeda K; Hisanaga T; Mabuchi N; Hayashi M; Ohnishi M; Sawaki M; Fujii M; Horie H; Sugimoto Y; Kinoshita M
Eur Heart J; 1999 Dec; 20(24):1799-807. PubMed ID: 10581138
[TBL] [Abstract][Full Text] [Related]
17. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.
Moertl D; Berger R; Struck J; Gleiss A; Hammer A; Morgenthaler NG; Bergmann A; Huelsmann M; Pacher R
J Am Coll Cardiol; 2009 May; 53(19):1783-90. PubMed ID: 19422985
[TBL] [Abstract][Full Text] [Related]
18. Plasma brain natriuretic peptide predicts short-term clinical outcome in heart failure patients with restrictive filling pattern.
Feola M; Aspromonte N; Milani L; Bobbio M; Bardellotto S; Barro S; Giovinazzo P; Noventa F; Valle R
J Card Fail; 2008 Jun; 14(5):420-5. PubMed ID: 18514935
[TBL] [Abstract][Full Text] [Related]
19. Plasma levels of atrial natriuretic peptide at peak exercise: a prognostic marker of cardiovascular-related death and heart transplantation in patients with moderate congestive heart failure.
de Groote P; Millaire A; Pigny P; Nugue O; Racadot A; Ducloux G
J Heart Lung Transplant; 1997 Sep; 16(9):956-63. PubMed ID: 9322147
[TBL] [Abstract][Full Text] [Related]
20. Clinical and prognostic value of Duke's Activity Status Index along with plasma B-type natriuretic peptide levels in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Parissis JT; Nikolaou M; Birmpa D; Farmakis D; Paraskevaidis I; Bistola V; Katsoulas T; Filippatos G; Kremastinos DT
Am J Cardiol; 2009 Jan; 103(1):73-5. PubMed ID: 19101233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
